Fosamax
NDC Package 0006-0077-44

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Fosamax is alendronate is used to prevent and treat certain types of bone loss (osteoporosis) in adults. Marketed by Merck Sharp & Dohme Corp., this product is identified by NDC 0006-0077 and is authorized under FDA application NDA020560.

Identification & Billing

NDC Package Code
0006-0077-44
Package Description
4 TABLET in 1 BLISTER PACK
Product Code
11-Digit Billing Format
00006007744

Clinical Specifications

Proprietary Name
Fosamax
Dosage Form
-
Usage Information
Alendronate is used to prevent and treat certain types of bone loss (osteoporosis) in adults. Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases as you age, after menopause, or if you are taking corticosteroid medications (such as prednisone) for a long time. This medication works by slowing bone loss. This effect helps maintain strong bones and reduce the risk of broken bones (fractures). Alendronate belongs to a class of drugs called bisphosphonates.

Regulatory & Marketing

Labeler Name
Merck Sharp & Dohme Corp.
FDA Application #
NDA020560
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
09-29-1995
End Marketing Date
07-10-2012
Listing Expiration
07-10-2012
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0006-0077). Click a package code to view its specific billing and regulatory data.

2 BLISTER PACK in 1 CARTON / 10 TABLET in 1 BLISTER PACK (0006-0077-01)

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0006-0077-44 identifies a specific commercial package of 4 tablet in 1 blister pack of Fosamax, labeled by Merck Sharp & Dohme Corp.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Merck Sharp & Dohme Corp. on September 29, 1995. The current certification is valid through July 10, 2012.

What are the primary indications for this medication?

Alendronate is used to prevent and treat certain types of bone loss (osteoporosis) in adults. Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases as you age, after menopause, or if you are taking corticosteroid medications (such as prednisone) for a long time. This medication works by slowing bone loss. This effect helps maintain strong bones and reduce the risk of broken bones (fractures). Alendronate belongs to a class of drugs called bisphosphonates.

How is this Merck Sharp & Dohme Corp. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00006007744. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0006-0077-44
11-Digit CMS (5-4-2)
00006-0077-44

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.